{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:56:29Z","timestamp":1757609789046,"version":"3.44.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15539-y","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:57:40Z","timestamp":1756666660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Major pathophysiological changes in pulmonary disease provided a molecular insight based on deep learning approach"],"prefix":"10.1038","volume":"15","author":[{"given":"Swaraj","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poornima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"issue":"2","key":"15539_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1128\/CMR.00060-07","volume":"21","author":"LB Gadkowski","year":"2008","unstructured":"Gadkowski, L. B. & Stout, J. E. Cavitary pulmonary disease. Clin. Microbiol. Rev. 21(2), 305\u2013333 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"15539_CR2","unstructured":"Becklake, M. R. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. 114(1), 187\u2013227. (1976)."},{"issue":"1","key":"15539_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1172\/JCI93556","volume":"128","author":"CK Garcia","year":"2018","unstructured":"Garcia, C. K. Insights from human genetic studies of lung and organ fibrosis. J. Clin. Invest. 128 (1), 36\u201344 (2018).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"15539_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-2600(12)70052-8","volume":"1","author":"CF Vogelmeier","year":"2013","unstructured":"Vogelmeier, C. F. et al. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol\u2013fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study. Lancet Respiratory Med. 1 (1), 51\u201360 (2013).","journal-title":"Lancet Respiratory Med."},{"issue":"6","key":"15539_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1183\/09031936.00150414","volume":"44","author":"SJ Singh","year":"2014","unstructured":"Singh, S. J. et al. An official systematic review of the European respiratory society\/american thoracic society: measurement properties of field walking tests in chronic respiratory disease. Eur. Respir. J. 44 (6), 1447\u20131478 (2014).","journal-title":"Eur. Respir J."},{"key":"15539_CR6","doi-asserted-by":"crossref","unstructured":"Behr, J. & Ryu, J. H. Pulmonary hypertension in interstitial lung disease. Eur. Respir. J. 31 (6), 1357\u20131367 (2008).","DOI":"10.1183\/09031936.00171307"},{"issue":"9","key":"15539_CR7","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1513\/AnnalsATS.201503-180OC","volume":"12","author":"NG Wysham","year":"2015","unstructured":"Wysham, N. G. et al. Symptom burden of chronic lung disease compared with lung cancer at time of referral for palliative care consultation. Annals Am. Thorac. Soc. 12 (9), 1294\u20131301 (2015).","journal-title":"Annals Am. Thorac. Soc."},{"issue":"32 suppl","key":"15539_CR8","doi-asserted-by":"publisher","first-page":"56s","DOI":"10.1183\/09031936.01.18s320056","volume":"32","author":"U Costabel","year":"2001","unstructured":"Costabel, U. Sarcoidosis: clinical update. Eur. Respir J. Suppl. 32 (32 suppl), 56s\u201368s (2001).","journal-title":"Eur. Respir J. Suppl."},{"issue":"1","key":"15539_CR9","first-page":"1","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez, F. J. et al. Idiopathic pulmonary fibrosis. Nat. Reviews Disease Primers. 3 (1), 1\u201319 (2017).","journal-title":"Nat. Reviews Disease Primers"},{"issue":"10082","key":"15539_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389 (10082), 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"15539_CR11","doi-asserted-by":"crossref","unstructured":"Barnes, P. J. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 118 (11), 3546\u20133556 (2008).","DOI":"10.1172\/JCI36130"},{"key":"15539_CR12","doi-asserted-by":"publisher","first-page":"101443","DOI":"10.1016\/j.redox.2020.101443","volume":"33","author":"M Manevski","year":"2020","unstructured":"Manevski, M. et al. Cellular stress responses and dysfunctional Mitochondrial\u2013cellular senescence, and therapeutics in chronic respiratory diseases. Redox Biol. 33, 101443 (2020).","journal-title":"Redox Biol."},{"issue":"1","key":"15539_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","volume":"19","author":"G Sgalla","year":"2018","unstructured":"Sgalla, G. et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 19 (1), 32 (2018).","journal-title":"Respir Res."},{"issue":"8","key":"15539_CR14","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36 (8), 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"issue":"5","key":"15539_CR15","doi-asserted-by":"publisher","first-page":"L683","DOI":"10.1152\/ajplung.00487.2021","volume":"322","author":"TS Mann","year":"2022","unstructured":"Mann, T. S. et al. Azithromycin inhibits mucin secretion, mucous metaplasia, airway inflammation, and airways hyperresponsiveness in mice exposed to house dust mite extract. Am. J. Physiol. Lung Cell. Mol. Physiol. 322 (5), L683\u2013L698 (2022).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"10 Pt 2","key":"15539_CR16","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1164\/ajrccm.164.supplement_2.2106061","volume":"164","author":"PK Jeffery","year":"2001","unstructured":"Jeffery, P. K. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir Crit. Care Med. 164 (10 Pt 2), S28\u201338 (2001).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"6","key":"15539_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1034\/j.1399-3003.2000.16f06.x","volume":"16","author":"P Aurora","year":"2000","unstructured":"Aurora, P. et al. A model for predicting life expectancy of children with cystic fibrosis. Eur. Respir J. 16 (6), 1056\u20131060 (2000).","journal-title":"Eur. Respir J."},{"key":"15539_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/JIR.S115508","volume":"10","author":"S Mavrogeni","year":"2017","unstructured":"Mavrogeni, S. et al. Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases. J. Inflamm. Res. 10, 55\u201361 (2017).","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"15539_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijcard.2013.12.079","volume":"171","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert, P. et al. Cardiac involvement in mixed connective tissue disease: a systematic review. Int. J. Cardiol. 171 (3), 326\u2013330 (2014).","journal-title":"Int. J. Cardiol."},{"issue":"25 Suppl","key":"15539_CR20","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","volume":"62","author":"W Seeger","year":"2013","unstructured":"Seeger, W. et al. Pulmonary hypertension in chronic lung diseases. J. Am. Coll. Cardiol. 62 (25 Suppl), D109\u2013D116 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"15539_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/ars.2014.6234","volume":"22","author":"F Veit","year":"2015","unstructured":"Veit, F. et al. Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels. Antioxid. Redox Signal. 22 (6), 537\u2013552 (2015).","journal-title":"Antioxid. Redox Signal."},{"key":"15539_CR22","volume-title":"Essentials of Cardiopulmonary Physical Therapy- E-Book","author":"E Hillegass","year":"2022","unstructured":"Hillegass, E. Essentials of Cardiopulmonary Physical Therapy- E-Book (Elsevier, 2022)."},{"issue":"14","key":"15539_CR23","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo, W. & Brouwer, C. Pathview: an r\/bioconductor package for pathway-based data integration and visualization. Bioinformatics 29 (14), 1830\u20131831 (2013).","journal-title":"Bioinformatics"},{"issue":"D1","key":"15539_CR24","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"15539_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10787-020-00698-3","volume":"28","author":"M Mehta","year":"2020","unstructured":"Mehta, M. et al. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacology 28 (4), 795\u2013817 (2020).","journal-title":"Inflammopharmacology"},{"key":"15539_CR26","doi-asserted-by":"publisher","first-page":"113918","DOI":"10.1016\/j.addr.2021.113918","volume":"178","author":"R Raguraman","year":"2021","unstructured":"Raguraman, R. et al. Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer. Adv. Drug Deliv Rev. 178, 113918 (2021).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"9373","key":"15539_CR27","first-page":"1967","volume":"361","author":"B Basnyat","year":"2003","unstructured":"Basnyat, B. & Murdoch, D. R. J. T. L. High-altitude Illn. 361(9373): 1967\u20131974. (2003).","journal-title":"High-altitude Illn."},{"issue":"20","key":"15539_CR28","doi-asserted-by":"publisher","first-page":"12656","DOI":"10.3390\/ijms232012656","volume":"23","author":"S El Alam","year":"2022","unstructured":"El Alam, S. et al. Inflammation in pulmonary hypertension and edema induced by hypobaric hypoxia exposure. Int. J. Mol. Sci. 23 (20), 12656 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"15539_CR29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.bcp.2013.02.009","volume":"85","author":"MC Chen","year":"2013","unstructured":"Chen, M. C. et al. Magnolol suppresses hypoxia-induced angiogenesis via Inhibition of HIF-1\u03b1\/VEGF signaling pathway in human bladder cancer cells. Biochem. Pharmacol. 85 (9), 1278\u20131287 (2013).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"15539_CR30","doi-asserted-by":"publisher","first-page":"16151","DOI":"10.1038\/srep16151","volume":"5","author":"C Wu","year":"2015","unstructured":"Wu, C. et al. Wnt\/\u03b2-catenin coupled with HIF-1\u03b1\/VEGF signaling pathways involved in Galangin neurovascular unit protection from focal cerebral ischemia. Sci. Rep. 5 (1), 16151 (2015).","journal-title":"Sci. Rep."},{"issue":"3","key":"15539_CR31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2020.10.022","volume":"147","author":"W Damsky","year":"2021","unstructured":"Damsky, W. et al. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases. J. Allergy Clin. Immunol. 147 (3), 814\u2013826 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"15539_CR32","first-page":"1","volume-title":"JAK-STAT Signaling in Diseases","author":"NN Houreld","year":"2020","unstructured":"Houreld, N. N. Regulation of Cytokine Signaling by the JAK-STAT Pathway. In JAK-STAT Signaling in Diseases 1\u20138 (CRC Press, 2020)."},{"issue":"15","key":"15539_CR33","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1073\/pnas.1700682114","volume":"114","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Cytokine receptor signaling is required for the survival of ALK\u2013 anaplastic large cell lymphoma, even in the presence of JAK1\/STAT3 mutations. Proc. Natl. Acad. Sci. 114 (15), 3975\u20133980 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"15539_CR34","doi-asserted-by":"publisher","first-page":"173394","DOI":"10.1016\/j.ejphar.2020.173394","volume":"884","author":"Q Guo","year":"2020","unstructured":"Guo, Q. et al. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1\u03b1\/VEGF signalling pathway in the bone environment. Eur. J. Pharmacol. 884, 173394 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"15539_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10456-013-9364-7","volume":"16","author":"PN Ganji","year":"2013","unstructured":"Ganji, P. N. et al. Antiangiogenic effects of Ganetespib in colorectal cancer mediated through Inhibition of HIF-1\u03b1 and STAT-3. Angiogenesis 16, 903\u2013917 (2013).","journal-title":"Angiogenesis"},{"key":"15539_CR36","doi-asserted-by":"crossref","unstructured":"Wu, C. et al. Wnt\/\u03b2-catenin coupled with HIF-1\u03b1\/VEGF signaling pathways involved in Galangin neurovascular unit protection from focal cerebral ischemia. Sci. Rep. 5(1), 1\u201311 (2015).","DOI":"10.1038\/srep16151"},{"key":"15539_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-319-33673-2_3","volume-title":"Tumor Angiogenesis: A Key Target for Cancer Therapy","author":"N Ferrara","year":"2019","unstructured":"Ferrara, N. The role of the Vegf signaling pathway in tumor angiogenesis. In Tumor Angiogenesis: A Key Target for Cancer Therapy 211\u2013226 (Springer, 2019)."},{"issue":"3","key":"15539_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","volume":"7","author":"K Nakano","year":"2001","unstructured":"Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7 (3), 683\u2013694 (2001).","journal-title":"Mol. Cell"},{"key":"15539_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-cancerbio-050216-121933","volume":"1","author":"A Letai","year":"2017","unstructured":"Letai, A. Apoptosis and cancer. Annual Rev. Cancer Biology. 1, 275\u2013294 (2017).","journal-title":"Annual Rev. Cancer Biology"},{"key":"15539_CR40","doi-asserted-by":"crossref","unstructured":"Aubrey, B. J. et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 25(1), 104\u2013113 (2018).","DOI":"10.1038\/cdd.2017.169"},{"issue":"1","key":"15539_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou, Z. et al. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell. Biosci. 10 (1), 31 (2020).","journal-title":"Cell. Biosci."},{"key":"15539_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cytogfr.2023.06.002","volume":"71-72","author":"Y Xie","year":"2023","unstructured":"Xie, Y. et al. mTOR in programmed cell death and its therapeutic implications. Cytokine Growth Factor. Rev. 71-72, 66\u201381 (2023).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"12","key":"15539_CR43","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.tcb.2013.07.006","volume":"23","author":"K Fernald","year":"2013","unstructured":"Fernald, K. & Kurokawa, M. Evading apoptosis in cancer. Trends Cell. Biol. 23 (12), 620\u2013633 (2013).","journal-title":"Trends Cell. Biol."},{"issue":"13","key":"15539_CR44","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.1074\/jbc.M109062200","volume":"277","author":"Y Li","year":"2002","unstructured":"Li, Y., Dowbenko, D. & Lasky, L. A. AKT\/PKB phosphorylation of p21Cip\/WAF1 enhances protein stability of p21Cip\/WAF1 and promotes cell survival. J. Biol. Chem. 277 (13), 11352\u201311361 (2002).","journal-title":"J. Biol. Chem."},{"issue":"34 suppl","key":"15539_CR45","doi-asserted-by":"publisher","first-page":"50s","DOI":"10.1183\/09031936.01.00229701","volume":"34","author":"KF Chung","year":"2001","unstructured":"Chung, K. F. Cytokines in chronic obstructive pulmonary disease. Eur. Respir J. Suppl. 34 (34 suppl), 50s\u201359s (2001).","journal-title":"Eur. Respir J. Suppl."},{"key":"15539_CR46","doi-asserted-by":"crossref","unstructured":"Barnes, P. J. The cytokine network in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 41(6), 631\u2013638 (2009).","DOI":"10.1165\/rcmb.2009-0220TR"},{"key":"15539_CR47","doi-asserted-by":"publisher","first-page":"983269","DOI":"10.3389\/fimmu.2022.983269","volume":"13","author":"BD Novita","year":"2022","unstructured":"Novita, B. D. et al. Characterization of chemokine and cytokine expression pattern in tuberculous lymphadenitis patient. Front. Immunol. 13, 983269 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"15539_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1165\/rcmb.2010-0264OC","volume":"45","author":"J Chao","year":"2011","unstructured":"Chao, J. et al. Monocyte chemoattractant protein\u20131 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia. Am. J. Respir. Cell Mol. Biol. 45 (1), 53\u201361 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"15539_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-4-12","volume":"4","author":"J Mojsilovic-Petrovic","year":"2007","unstructured":"Mojsilovic-Petrovic, J. et al. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1\/CCL2) and MCP-5 (Ccl12) in astrocytes. J. Neuroinflamm. 4 (1), 1\u201315 (2007).","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"15539_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1165\/rcmb.2012-0137TR","volume":"48","author":"S Fr\u00f6hlich","year":"2013","unstructured":"Fr\u00f6hlich, S., Boylan, J. & McLoughlin, P. Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? Am. J. Respir. Cell Mol. Biol. 48 (3), 271\u2013279 (2013).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"15539_CR51","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3390\/ijms20092218","volume":"20","author":"YT Li","year":"2019","unstructured":"Li, Y. T. et al. Monocyte chemoattractant Protein-1, a possible biomarker of multiorgan failure and mortality in Ventilator-Associated pneumonia. Int. J. Mol. Sci. 20 (9), 2218 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"15539_CR52","doi-asserted-by":"publisher","first-page":"798338","DOI":"10.3389\/fimmu.2021.798338","volume":"12","author":"T Ebihara","year":"2021","unstructured":"Ebihara, T. et al. Cytokine elevation in severe COVID-19 from longitudinal proteomics analysis: comparison with sepsis. Front. Immunol. 12, 798338 (2021).","journal-title":"Front. Immunol."},{"issue":"9","key":"15539_CR53","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/jbmr.2848","volume":"31","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling. J. Bone Min. Res. 31 (9), 1652\u20131665 (2016).","journal-title":"J. Bone Min. Res."},{"key":"15539_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","volume":"64","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui, J. A. et al. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. Cytokine Growth Factor. Rev. 64, 71\u201383 (2022).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"6","key":"15539_CR55","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1165\/rcmb.2018-0379TR","volume":"60","author":"FM Verhamme","year":"2019","unstructured":"Verhamme, F. M. et al. GDF-15 in pulmonary and critical care medicine. Am. J. Respir Cell. Mol. Biol. 60 (6), 621\u2013628 (2019).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"15539_CR56","doi-asserted-by":"crossref","unstructured":"Alserawan, L. et al. Growth differentiation factor 15 (GDF-15): a novel biomarker associated with poorer respiratory function in COVID-19. Diagnostics. 11 (11), 1998 (2021).","DOI":"10.3390\/diagnostics11111998"},{"key":"15539_CR57","doi-asserted-by":"crossref","unstructured":"Torrealba, N. et al. TGF-\u03b2\/PI3K\/AKT\/mTOR\/NF-kB pathway. Clinicopathological features in prostate cancer. Aging Male\u00a0(2019).","DOI":"10.1080\/13685538.2019.1597840"},{"issue":"1","key":"15539_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ijms22010173","volume":"22","author":"D Miricescu","year":"2020","unstructured":"Miricescu, D. et al. PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int. J. Mol. Sci. 22 (1), 173 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"15539_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0803-3","volume":"17","author":"N Haddadi","year":"2018","unstructured":"Haddadi, N. et al. PTEN\/PTENP1:\u2018Regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy. Mol. Cancer. 17 (1), 1\u201314 (2018).","journal-title":"Mol. Cancer"},{"issue":"4","key":"15539_CR60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cell.2005.10.024","volume":"123","author":"MK Holz","year":"2005","unstructured":"Holz, M. K. et al. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123 (4), 569\u2013580 (2005).","journal-title":"Cell"},{"issue":"6","key":"15539_CR61","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","volume":"9","author":"M Osaki","year":"2004","unstructured":"Osaki, M., Oshimura, M. & Ito, H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9 (6), 667\u2013676 (2004).","journal-title":"Apoptosis"},{"issue":"1","key":"15539_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He, Y. et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal. Transduct. Target. Ther. 6 (1), 425 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"15539_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Z Du","year":"2018","unstructured":"Du, Z. & Lovly, C. M. Mechanisms of receptor tyrosine kinase activation in cancer. Mol. Cancer. 17 (1), 58 (2018).","journal-title":"Mol. Cancer"},{"key":"15539_CR64","doi-asserted-by":"publisher","first-page":"772510","DOI":"10.3389\/fphar.2021.772510","volume":"12","author":"S Sudhesh Dev","year":"2021","unstructured":"Sudhesh Dev, S. et al. Receptor tyrosine kinases and their signaling pathways as therapeutic targets of Curcumin in cancer. Front. Pharmacol. 12, 772510 (2021).","journal-title":"Front. Pharmacol."},{"issue":"31","key":"15539_CR65","doi-asserted-by":"publisher","first-page":"22584","DOI":"10.1074\/jbc.M112.421636","volume":"288","author":"K Nakayama","year":"2013","unstructured":"Nakayama, K. cAMP-response element-binding protein (CREB) and NF-\u03baB transcription factors are activated during prolonged hypoxia and cooperatively regulate the induction of matrix metalloproteinase MMP1. J. Biol. Chem. 288 (31), 22584\u201322595 (2013).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"15539_CR66","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1210\/en.2011-1895","volume":"153","author":"K Velmurugan","year":"2012","unstructured":"Velmurugan, K. et al. Antiapoptotic actions of exendin-4 against hypoxia and cytokines are augmented by CREB. Endocrinology 153 (3), 1116\u20131128 (2012).","journal-title":"Endocrinology"},{"key":"15539_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2016.07.006","volume":"30","author":"I Kufareva","year":"2016","unstructured":"Kufareva, I. Chemokines and their receptors: insights from molecular modeling and crystallography. Curr. Opin. Pharmacol. 30, 27\u201337 (2016).","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"15539_CR68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2567.2002.01345.x","volume":"105","author":"AP Curnock","year":"2002","unstructured":"Curnock, A. P., Logan, M. K. & Ward, S. G. Chemokine signalling: Pivoting around multiple phosphoinositide 3-kinases. Immunology 105 (2), 125\u2013136 (2002).","journal-title":"Immunology"},{"issue":"1","key":"15539_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. The JAK\/STAT signaling pathway: from bench to clinic. Signal. Transduct. Target. Ther. 6 (1), 402 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"16","key":"15539_CR70","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1182\/blood-2014-04-568451","volume":"124","author":"AM de Bruin","year":"2014","unstructured":"de Bruin, A. M., Voermans, C. & Nolte, M. A. Impact of interferon-gamma on hematopoiesis. Blood 124 (16), 2479\u20132486 (2014).","journal-title":"Blood"},{"issue":"8","key":"15539_CR71","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/cells8080854","volume":"8","author":"F Perner","year":"2019","unstructured":"Perner, F. et al. Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation. Cells 8 (8), 854 (2019).","journal-title":"Cells"},{"issue":"20","key":"15539_CR72","first-page":"3092","volume":"124","author":"S Degryse","year":"2014","unstructured":"Degryse, S. et al. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model. Blood J. Am. Soc. Hematol. 124 (20), 3092\u20133100 (2014).","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"10","key":"15539_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/omi.2011.0160","volume":"16","author":"V Randhawa","year":"2012","unstructured":"Randhawa, V. & Bagler, G. Identification of SRC as a potent drug target for asthma, using an integrative approach of protein interactome analysis and in Silico drug discovery. Omics: J. Integr. Biology. 16 (10), 513\u2013526 (2012).","journal-title":"Omics: J. Integr. Biology"},{"issue":"1","key":"15539_CR74","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12931-017-0694-7","volume":"18","author":"D Toumpanakis","year":"2017","unstructured":"Toumpanakis, D. et al. The role of Src & ERK1\/2 kinases in inspiratory resistive breathing induced acute lung injury and inflammation. Respir Res. 18 (1), 209 (2017).","journal-title":"Respir Res."},{"issue":"2","key":"15539_CR75","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3892\/etm.2021.11095","volume":"23","author":"M Wu","year":"2022","unstructured":"Wu, M. et al. Effect of Src tyrosine kinase on a rat model of asthma. Exp. Ther. Med. 23 (2), 172 (2022).","journal-title":"Exp. Ther. Med."},{"key":"15539_CR76","doi-asserted-by":"crossref","unstructured":"Anderson, G. P. & Bozinovski, s. Acquired somatic mutations in the molecular pathogenesis of COPD. 24(2), 71\u201376 (2003).","DOI":"10.1016\/S0165-6147(02)00052-4"},{"issue":"4","key":"15539_CR77","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1183\/09031936.00082308","volume":"32","author":"L Mascitelli","year":"2008","unstructured":"Mascitelli, L., Pezzetta, F. & Goldstein, M. Inhibition of the renin\u2013angiotensin system in severe COPD. Eur. Respir. J. 32 (4), 1130\u20131130 (2008).","journal-title":"Eur. Respir. J."},{"issue":"22","key":"15539_CR78","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1111\/bph.15619","volume":"178","author":"JF Greg\u00f3rio","year":"2021","unstructured":"Greg\u00f3rio, J. F. et al. Asthma: role of the angiotensin-(1\u20107)\/Mas (MAS1) pathway in pathophysiology and therapy. Br. J. Pharmacol. 178 (22), 4428\u20134439 (2021).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"15539_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40364-018-0128-9","volume":"6","author":"T Southworth","year":"2018","unstructured":"Southworth, T. et al. PI3K, p38 and JAK\/STAT signalling in bronchial tissue from patients with asthma following allergen challenge. Biomark. Res. 6 (1), 14 (2018).","journal-title":"Biomark. Res."},{"issue":"1","key":"15539_CR80","doi-asserted-by":"publisher","first-page":"e000114","DOI":"10.1136\/bmjresp-2015-000114","volume":"3","author":"PA Crosbie","year":"2016","unstructured":"Crosbie, P. A. et al. ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing. BMJ Open. Respir Res. 3 (1), e000114 (2016).","journal-title":"BMJ Open. Respir Res."},{"issue":"6","key":"15539_CR81","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1159\/000108783","volume":"74","author":"M Xie","year":"2007","unstructured":"Xie, M. et al. ERK1\/2 signaling pathway modulates the airway smooth muscle cell phenotype in the rat model of chronic asthma. Respiration 74 (6), 680\u2013690 (2007).","journal-title":"Respiration"},{"issue":"4","key":"15539_CR82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/1389200220666190227224748","volume":"20","author":"X Sun","year":"2019","unstructured":"Sun, X., Chen, L. & He, Z. PI3K\/Akt-Nrf2 and Anti-Inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr. Drug Metab. 20 (4), 301\u2013304 (2019).","journal-title":"Curr. Drug Metab."},{"issue":"5","key":"15539_CR83","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41397-017-0006-0","volume":"18","author":"A Dahlin","year":"2018","unstructured":"Dahlin, A. et al. The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of Zileuton response in adults with asthma. Pharmacogenomics J. 18 (5), 665\u2013677 (2018).","journal-title":"Pharmacogenomics J."},{"key":"15539_CR84","doi-asserted-by":"crossref","unstructured":"Sandri, B. J. et al. Multi-omic molecular profiling of lung cancer in COPD. Eur. Respir J.\u00a052(1) (2018).","DOI":"10.1183\/13993003.02665-2017"},{"issue":"45","key":"15539_CR85","doi-asserted-by":"publisher","first-page":"42596","DOI":"10.1074\/jbc.M205863200","volume":"277","author":"US Kayyali","year":"2002","unstructured":"Kayyali, U. S. et al. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J. Biol. Chem. 277 (45), 42596\u201342602 (2002).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"15539_CR86","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1165\/rcmb.2005-0478OC","volume":"35","author":"D Bouvry","year":"2006","unstructured":"Bouvry, D. et al. Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells. Am. J. Respir Cell. Mol. Biol. 35 (5), 519\u2013527 (2006).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"issue":"5","key":"15539_CR87","doi-asserted-by":"publisher","first-page":"e01134","DOI":"10.1002\/cti2.1134","volume":"9","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. RhoA\/Rho-kinases in asthma: from pathogenesis to therapeutic targets. Clin. Transl Immunol. 9 (5), e01134 (2020).","journal-title":"Clin. Transl Immunol."},{"issue":"3","key":"15539_CR88","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13665-013-0052-2","volume":"2","author":"S Ganesan","year":"2013","unstructured":"Ganesan, S. & Sajjan, U. S. Repair and remodeling of airway epithelium after injury in chronic obstructive pulmonary disease. Curr. Respir Care Rep. 2 (3), 145\u2013154 (2013).","journal-title":"Curr. Respir Care Rep."},{"key":"15539_CR89","doi-asserted-by":"crossref","unstructured":"Nagaraj, C. et al. Hypoxic vascular response and ventilation\/perfusion matching in end-stage COPD May depend on p22phox. Eur. Respir J.\u00a050(1) (2017).","DOI":"10.1183\/13993003.01651-2016"},{"key":"15539_CR90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.toxlet.2017.03.002","volume":"272","author":"YI Chirino","year":"2017","unstructured":"Chirino, Y. I. et al. Airborne particulate matter in vitro exposure induces cytoskeleton remodeling through activation of the ROCK-MYPT1-MLC pathway in A549 epithelial lung cells. Toxicol. Lett. 272, 29\u201337 (2017).","journal-title":"Toxicol. Lett."},{"issue":"1","key":"15539_CR91","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1038\/s41598-018-27321-4","volume":"8","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. The level of ROCK1 and ROCK2 in patients with pulmonary hypertension in plateau area. Sci. Rep. 8 (1), 9356 (2018).","journal-title":"Sci. Rep."},{"key":"15539_CR92","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3389\/fphar.2018.01369","volume":"9","author":"J van Gastel","year":"2018","unstructured":"van Gastel, J. et al. beta-Arrestin based receptor signaling paradigms: potential therapeutic targets for complex Age-Related disorders. Front. Pharmacol. 9, 1369 (2018).","journal-title":"Front. Pharmacol."},{"issue":"11","key":"15539_CR93","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/aps.2015.74","volume":"36","author":"YJ Gu","year":"2015","unstructured":"Gu, Y. J. et al. The emerging roles of beta-arrestins in fibrotic diseases. Acta Pharmacol. Sin. 36 (11), 1277\u20131287 (2015).","journal-title":"Acta Pharmacol. Sin"},{"issue":"1","key":"15539_CR94","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/rr195","volume":"4","author":"CK Billington","year":"2003","unstructured":"Billington, C. K. & Penn, R. B. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res. 4 (1), 2 (2003).","journal-title":"Respir Res."},{"issue":"4","key":"15539_CR95","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/01.STR.0000121644.82596.7e","volume":"35","author":"MS Lombardi","year":"2004","unstructured":"Lombardi, M. S. et al. Hypoxia\/ischemia modulates G protein\u2013coupled receptor kinase 2 and \u03b2-arrestin-1 levels in the neonatal rat brain. Stroke 35 (4), 981\u2013986 (2004).","journal-title":"Stroke"},{"issue":"11","key":"15539_CR96","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/s41418-021-00802-2","volume":"28","author":"WY Bae","year":"2021","unstructured":"Bae, W. Y. et al. \u03b2-arrestin 2 stimulates degradation of HIF-1\u03b1 and modulates tumor progression of glioblastoma. Cell. Death Differ. 28 (11), 3092\u20133104 (2021).","journal-title":"Cell. Death Differ."},{"issue":"23","key":"15539_CR97","doi-asserted-by":"publisher","first-page":"12999","DOI":"10.1128\/JVI.02103-13","volume":"87","author":"IN Gavrilovskaya","year":"2013","unstructured":"Gavrilovskaya, I. N., Gorbunova, E. E. & Mackow, E. R. Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway. J. Virol. 87 (23), 12999\u201313008 (2013).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15539-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:24:54Z","timestamp":1756898694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15539-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15539-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Does not involve any animal or human subjects hence not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agreed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"32024"}}